Skip to main content
OpenTrials
Completed

NCT Number: NCT05286190

Caudal Block and Transversus Abdominis Plane Block in Pediatric Inguinal Hernia Repair

Pediatric inguinal hernia repair (IHR) candidates experiences ordinarily mild to moderate pain, rarely severe pain in the postoperative period. Caudal epidural block (CEB) and transversus abdominis plane block (TAPB) are two effective postoperative analgesia options. In this randomized study, it is aimed to compare the effects of CEB and TAPB on postoperative pain scores, additional analgesic requirement, postoperative nausea and vomiting incidence, procedural complications, family and surgeon satisfaction, length of hospital stay, chronic pain development in pediatric bilateral open IHR.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–7 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Meltem Savran Karadeniz

Istanbul, Fatih, 34000, Turkey (Türkiye)

About this study

Inguinal hernia repair (IHR) is the second common operation in pediatric surgery practice following appendectomy and bilateral repair is needed in 10.9% of the cases due to presence of contralateral inguinal hernia. After IHR, the children generally experiences mild to moderate pain, and occasional severe pain. For pediatric population the prevalence of chronic pain after IHR is 5% which is a solid cause for severe pain.

Adequate pain control is a crucial part of perioperative management to reduce morbidity and ensure family and patient satisfaction especially after pediatric surgeries. Although there are substantial studies to show how to assess and manage the postoperative pain in children, the pain control is often not achieved. Several analgesic regimens including systemic medications and/or regional analgesia methods may be preferred by clinicians. As previous studies revealed; best combination for pain management after pediatric IHR is still obscure.

Caudal epidural block (CEB) and transversus abdominis plane block (TAPB) are the two regional analgesia methods which may be chosen for multimodal analgesia. CEB is accepted as gold standard for lower abdominal surgeries in children which diminishes somatic and visceral pain with a duration of 6 hours. TAPB is another regional analgesia method which covers only somatic pain up to 24 hours postoperatively with lower complication rates compared to CEB. The results of clinical studies examining the effects of CEB and TAPB on early postoperative pain after pediatric IHR are conflicting. Currently, the effects of these blocks on the incidence of chronic pain after pediatric IHR is not well-investigated in the literature. As a matter of fact, there are no recommendations for bilateral IHR in pediatric postoperative pain guidelines, despite these surgical procedures being an independent risk factor for severe pain.

In this randomized study, it is aimed to compare the effects of ultrasound (US) guided CEB and TAPB on postoperative analgesia. Our hypothesis was that bilateral TAPB block will be equally effective as CEB in the early postoperative period and the analgesic duration will be longer than CEB. Our primary outcome was FLACC (face, legs, activity, cry, consolability) scores in postoperative 24 hours. The secondary outcomes included additional analgesic requirements, postoperative nausea vomiting incidence, procedural complications, length of hospital stay, family and surgeon satisfaction and chronic pain development at the postoperative 2nd month.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients aged 1-7 years who were scheduled for elective bilateral open IHR included in the study

Exclusion criteria

  • Patients with relative or absolute contraindications to TAPB or CEB, patients with chronic constipation or chronic pain disorders that may affect the evaluation of postoperative pain scores, patients who underwent emergency surgery, and patients with a history of allergic reaction to local anesthetics were excluded from the study.

Treatment and study plan

Bupivacaine 0.25% Injectable Solution

Drug

Bupivacaine 0.25% Injectable Solution

Other names: Marcaine

Primary outcomes

  1. FLACC SCORES (FACE, LEG, ACTIVITY, CONSOLABILITY, CRY)

    Time frame: Up to 24 hours

    It includes five categories of behavior, each scored on 0-2 point scale so that total score ranges from 0 to 10. Total scores of 0-3 is defined as mild, 4-7 as moderate, and 8-10 as severe pain.

Secondary outcomes

  1. PONV (Postoperative nausea and vomiting)

    Time frame: Up to 24 hours

    Number of patients with nausea vomiting

  2. Additional analgesic requirement

    Time frame: Up to 24 hours

    Number of patients who require paracetamol (15 mg/kg) and tramadol (1 mg/kg)

  3. Family satisfaction

    Time frame: Up to 24 hours

    A 3-point scale (satisfied:3; neutral:2, dissatisfied:1)

  4. Surgeon satisfaction

    Time frame: Up to 24 hours

    A 3-point scale (satisfied:3; neutral:2, dissatisfied:1)

  5. Complications

    Time frame: Up to 24 hours

    Possible complications related to caudal and transversus abdominis plane block (hematoma, infection and perforation)

  6. Revised Bieri faces pain scale

    Time frame: At postoperative 2nd month

    Revised Bieri faces pain scale used for assessment of chronic pain. Score the chosen face 0,2,4,6,8,10 counting left to right so '0'=no pain and '10'=very much pain

  7. Length of hospital stay

    Time frame: Through study completion, an average of 1 week

    Hospitalisation

Sponsors and collaborators

Lead sponsor

Istanbul University

Other

Registry information

Official study title

Effects Of Ultrasound Guided Caudal Epidural And Transversus Abdominis Plane Block On Postoperative Analgesia In Pediatric Inguinal Hernia Repair Surgeries

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 18, 2022
Registry last updated
Apr 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.